Skip to main content
SpringerLink
Log in

Amsacrine administration: A precautionary note

  • Letter to the Editors
  • Amsacrine Administration
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Arlin ZA, Sklaroff RB, Gee TS, Kempin SJ Howard J, Clarkson BD, Young CS (1980) Phase I and II trial of 4′-(9-acridinylamino) methanesulfon-m-anisidide in patients with acute leukemia. Cancer Res 40:3304

    Google Scholar 

  2. Legha SS, Keating MJ, Zander AR, McCredie KB, Bodey GP, Freireich EJ (1980) 4′-(9-acridinylamino) Methanesulfon-m-anisidide (AMSA): A new drug effective in the treatment of adult acute leukemia. Ann Intern Med 93:17

    Google Scholar 

  3. National Cancer Institute (1983) NCI Investigational Drug Pharmaceutical Data. NIH Publikation 10. 83–2141, p 161

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Neoplastic Diseases, New York Medical College/Westchester County Medical Center, 10595, Valhalla, NY, USA

    Constance Engelking, Phyllis Sullivan, Glen Agoliati & Zalmen A. Arlin

Authors
  1. Constance Engelking
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Phyllis Sullivan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Glen Agoliati
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zalmen A. Arlin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Engelking, C., Sullivan, P., Agoliati, G. et al. Amsacrine administration: A precautionary note. Cancer Chemother. Pharmacol. 13, 150 (1984). https://doi.org/10.1007/BF00257136

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00257136

Keywords

Search

Navigation